.

Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Find generic sources and suppliers
  • Formulary management

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

DrugPatentWatch Database Preview

Cytarabine - Generic Drug Details

« Back to Dashboard

What are the generic drug sources, and freedom to operate, for cytarabine?

Cytarabine is the generic ingredient in three branded drugs marketed by Teva Pharms Usa, Fresenius Kabi Usa, Mylan Labs Ltd, Mylan Pharms Inc, Pacira Pharms Inc, Hospira, West-ward Pharms Int, and Teva Parenteral, and is included in fifteen NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

There are fifteen drug master file entries for cytarabine. Six suppliers are listed for this compound.

Summary for Generic Name: cytarabine

Tradenames:3
Patents:1
Applicants:8
NDAs:15
Drug Master File Entries: see list15
Suppliers / Packagers: see list6
Bulk Api Vendors: see list73
Clinical Trials: see list445
Patent Applications: see list9,938
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:cytarabine at DailyMed

Pharmacology for Ingredient: cytarabine

Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Teva Parenteral
CYTARABINE
cytarabine
INJECTABLE;INJECTION016793-004Dec 21, 1987DISCNYesNo► Subscribe► Subscribe
Mylan Labs Ltd
CYTARABINE
cytarabine
INJECTABLE;INJECTION200914-001Dec 13, 2011RXNoNo► Subscribe► Subscribe
Teva Parenteral
CYTARABINE
cytarabine
INJECTABLE;INJECTION016793-001Approved Prior to Jan 1, 1982DISCNYesNo► Subscribe► Subscribe
Teva Pharms Usa
CYTOSAR-U
cytarabine
INJECTABLE;INJECTION075206-001Dec 30, 1998RXNoNo► Subscribe► Subscribe
Teva Pharms Usa
CYTOSAR-U
cytarabine
INJECTABLE;INJECTION075206-003Dec 30, 1998RXNoYes► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: cytarabine

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Pacira Pharms Inc
DEPOCYT
cytarabine
INJECTABLE, LIPOSOMAL;INJECTION021041-001Apr 1, 19995,455,044► Subscribe
Teva Parenteral
CYTARABINE
cytarabine
INJECTABLE;INJECTION016793-002Approved Prior to Jan 1, 19823,444,294► Subscribe
Pacira Pharms Inc
DEPOCYT
cytarabine
INJECTABLE, LIPOSOMAL;INJECTION021041-001Apr 1, 19995,723,147► Subscribe
Teva Parenteral
CYTARABINE
cytarabine
INJECTABLE;INJECTION016793-001Approved Prior to Jan 1, 19823,444,294► Subscribe
Pacira Pharms Inc
DEPOCYT
cytarabine
INJECTABLE, LIPOSOMAL;INJECTION021041-001Apr 1, 19996,071,534► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc